LEVETIRACETAM ORAL vs RUFINAMIDE

Compare LEVETIRACETAM ORAL (Levetiracetam) and RUFINAMIDE (Banzel) — clinical data, side effects, and patient experiences.

LEVETIRACETAM ORAL

Levetiracetam · Anticonvulsant

How it works

12.1 Mechanism of Action The precise mechanism(s) by which levetiracetam exerts its antiepileptic effect is unknown. A saturable and stereoselective neuronal binding site in rat br...

Approved for

See full prescribing information

OralTablet

RUFINAMIDE

Banzel · Anticonvulsant

How it works

12.1 Mechanism of Action The precise mechanism(s) by which rufinamide exerts its antiepileptic effect is unknown. The results of in vitro studies suggest that the principal mechani...

Approved for

and in adults ( 1 )

OralTablet

Quick Comparison

LEVETIRACETAM ORALRUFINAMIDE

Drug Class

Anticonvulsant

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

LEVETIRACETAM ORAL

Drug Not Working

>10%

Fatigue

1-10%

Drowsiness

0.1-1%

Falls

0.1-1%

Headache

0.1-1%

Dizziness

0.1-1%

Nausea

0.1-1%

Diarrhea

0.1-1%

RUFINAMIDE

Drug Not Working

>10%

Drowsiness

1-10%

Diarrhea

0.1-1%

Condition Worsened

0.1-1%

Vomiting

0.1-1%

Fatigue

0.1-1%

Falls

0.1-1%

Decreased Appetite

0.1-1%

FDA Warnings

LEVETIRACETAM ORAL

5 WARNINGS AND PRECAUTIONS • Behavioral abnormalities including psychotic symptoms, suicidal ideation, irritability, and aggressive behavior have been observed; monitor patients for psychiatric signs and symptoms ( 5
3 ) • Serious Dermatological Reactions: Discontinue levetiracetam at the first sign of rash unless clearly not drug related (5
2 Suicidal Behavior and Ideation Antiepileptic drugs (AEDs), including levetiracetam, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication
Pooled analyses of 199 placebo-controlled clinical trials (mono- and adjunctive therapy) of 11 different AEDs showed that patients randomized to one of the AEDs had approximately twice the risk (adjusted Relative Risk 1

RUFINAMIDE

5 WARNINGS AND PRECAUTIONS Monitor patients for new or worsening depression, suicidal thoughts/behavior, and unusual changes in mood or behavior ( 5
4 ) Withdraw BANZEL gradually to minimize the risk of precipitating seizures, seizure exacerbation, or status epilepticus ( 5
1 Suicidal Behavior and Ideation Antiepileptic drugs (AEDs), including BANZEL, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication
Pooled analyses of 199 placebo-controlled clinical trials (mono- and adjunctive therapy) of 11 different AEDs showed that patients randomized to one of the AEDs had approximately twice the risk (adjusted Relative Risk 1

Clinical Trial Data

No head-to-head clinical studies found for LEVETIRACETAM ORAL vs RUFINAMIDE.

LEVETIRACETAM ORAL vs RUFINAMIDE: What You Should Know

Key Differences

Both LEVETIRACETAM ORAL and RUFINAMIDE belong to the Anticonvulsant class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

LEVETIRACETAM ORAL carries 4 FDA warnings. RUFINAMIDE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

LACOSAMIDE vs LEVETIRACETAM ORAL→LEVETIRACETAM ORAL vs PREGABALIN→LEVETIRACETAM ORAL vs PHENYTOIN SODIUM→CARBAMAZEPINE vs LEVETIRACETAM ORAL→LEVETIRACETAM ORAL vs ZONISAMIDE→EXTENDED PHENYTOIN SODIUM vs LEVETIRACETAM ORAL→

Loading comparison data...

LEVETIRACETAM ORAL vs RUFINAMIDE

Compare LEVETIRACETAM ORAL (Levetiracetam) and RUFINAMIDE (Banzel) — clinical data, side effects, and patient experiences.

LEVETIRACETAM ORAL

Levetiracetam · Anticonvulsant

How it works

12.1 Mechanism of Action The precise mechanism(s) by which levetiracetam exerts its antiepileptic effect is unknown. A saturable and stereoselective neuronal binding site in rat br...

Approved for

See full prescribing information

OralTablet

RUFINAMIDE

Banzel · Anticonvulsant

How it works

12.1 Mechanism of Action The precise mechanism(s) by which rufinamide exerts its antiepileptic effect is unknown. The results of in vitro studies suggest that the principal mechani...

Approved for

and in adults ( 1 )

OralTablet

Quick Comparison

LEVETIRACETAM ORALRUFINAMIDE

Drug Class

Anticonvulsant

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

LEVETIRACETAM ORAL

Drug Not Working

>10%

Fatigue

1-10%

Drowsiness

0.1-1%

Falls

0.1-1%

Headache

0.1-1%

Dizziness

0.1-1%

Nausea

0.1-1%

Diarrhea

0.1-1%

RUFINAMIDE

Drug Not Working

>10%

Drowsiness

1-10%

Diarrhea

0.1-1%

Condition Worsened

0.1-1%

Vomiting

0.1-1%

Fatigue

0.1-1%

Falls

0.1-1%

Decreased Appetite

0.1-1%

FDA Warnings

LEVETIRACETAM ORAL

5 WARNINGS AND PRECAUTIONS • Behavioral abnormalities including psychotic symptoms, suicidal ideation, irritability, and aggressive behavior have been observed; monitor patients for psychiatric signs and symptoms ( 5
3 ) • Serious Dermatological Reactions: Discontinue levetiracetam at the first sign of rash unless clearly not drug related (5
2 Suicidal Behavior and Ideation Antiepileptic drugs (AEDs), including levetiracetam, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication
Pooled analyses of 199 placebo-controlled clinical trials (mono- and adjunctive therapy) of 11 different AEDs showed that patients randomized to one of the AEDs had approximately twice the risk (adjusted Relative Risk 1

RUFINAMIDE

5 WARNINGS AND PRECAUTIONS Monitor patients for new or worsening depression, suicidal thoughts/behavior, and unusual changes in mood or behavior ( 5
4 ) Withdraw BANZEL gradually to minimize the risk of precipitating seizures, seizure exacerbation, or status epilepticus ( 5
1 Suicidal Behavior and Ideation Antiepileptic drugs (AEDs), including BANZEL, increase the risk of suicidal thoughts or behavior in patients taking these drugs for any indication
Pooled analyses of 199 placebo-controlled clinical trials (mono- and adjunctive therapy) of 11 different AEDs showed that patients randomized to one of the AEDs had approximately twice the risk (adjusted Relative Risk 1

Clinical Trial Data

No head-to-head clinical studies found for LEVETIRACETAM ORAL vs RUFINAMIDE.

LEVETIRACETAM ORAL vs RUFINAMIDE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.